Novartis is proud to partner with UK-based advanced breast cancer specialist nurses to draw focus to the everyday reality for women living with the disease.
Melanoma patients, carers and their friends and family share their experiences of the impact of a melanoma diagnosis.
New report, commissioned by Novartis, looks at how changing the way that the NHS pays for medicines could deliver better outcomes for patients.
Hear from Richard Jarvis, Head of Corporate Affairs UK, on the recent UK BioIndustry Association visit to the Novartis headquarters
This site is intended for an audience in the United Kingdom